201 related articles for article (PubMed ID: 31620664)
1. Circular RNAs and neutrophils: Key factors in tackling asymptomatic moyamoya disease.
Corey S; Luo Y
Brain Circ; 2019; 5(3):150-155. PubMed ID: 31620664
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA profiling of neutrophil transcriptome provides insights into asymptomatic Moyamoya disease.
Ma Q; Li L; Yu B; Jiao L; Han Z; Zhao H; Li G; Ma Y; Luo Y
Brain Res; 2019 Sep; 1719():104-112. PubMed ID: 31132337
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of circular RNAs in Moyamoya disease.
Zhao M; Gao F; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
J Neurol Sci; 2017 Oct; 381():25-31. PubMed ID: 28991692
[TBL] [Abstract][Full Text] [Related]
4. TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease.
Chen Y; Tang M; Li H; Liu H; Wang J; Huang J
Front Neurol; 2022; 13():899470. PubMed ID: 35873760
[TBL] [Abstract][Full Text] [Related]
5. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
6. An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues.
Kim JE; Jeon JS
Neurol Res; 2014 May; 36(5):407-16. PubMed ID: 24641716
[TBL] [Abstract][Full Text] [Related]
7. Moyamoya Disease.
Fujimura M; Bang OY; Kim JS
Front Neurol Neurosci; 2016; 40():204-220. PubMed ID: 27960175
[TBL] [Abstract][Full Text] [Related]
8. Incidental Moyamoya Disease in an Elderly Patient Presenting With Acute Ischemic Pontine Stroke.
Abou-El-Hassan H; Azhand H; Kantono M; Bhagat A; Karp D; Baranski T; Salahuddin T; Farmand F
Cureus; 2023 Mar; 15(3):e36198. PubMed ID: 37065418
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic Moyamoya Disease : A Recent Update.
Fujimura M; Tominaga T
J Korean Neurosurg Soc; 2019 Mar; 62(2):136-143. PubMed ID: 30428637
[TBL] [Abstract][Full Text] [Related]
10. Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma.
Liu W; Zhang J; Zou C; Xie X; Wang Y; Wang B; Zhao Z; Tu J; Wang X; Li H; Shen J; Yin J
Cell Physiol Biochem; 2017; 43(3):969-985. PubMed ID: 28957794
[TBL] [Abstract][Full Text] [Related]
11. Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease.
Blecharz-Lang KG; Prinz V; Burek M; Frey D; Schenkel T; Krug SM; Fromm M; Vajkoczy P
J Cereb Blood Flow Metab; 2018 Nov; 38(11):1940-1953. PubMed ID: 29633884
[TBL] [Abstract][Full Text] [Related]
12. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease.
Takagi Y; Kikuta K; Nozaki K; Fujimoto M; Hayashi J; Imamura H; Hashimoto N
Neurosurgery; 2007 Feb; 60(2):338-45; discussion 345. PubMed ID: 17290185
[TBL] [Abstract][Full Text] [Related]
14. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Moyamoya Disease and
Lee MJ; Fallen S; Zhou Y; Baxter D; Scherler K; Kuo MF; Wang K
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31658621
[TBL] [Abstract][Full Text] [Related]
16. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
[TBL] [Abstract][Full Text] [Related]
17. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report.
Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153
[TBL] [Abstract][Full Text] [Related]
18. Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells.
Hamauchi S; Shichinohe H; Uchino H; Yamaguchi S; Nakayama N; Kazumata K; Osanai T; Abumiya T; Houkin K; Era T
PLoS One; 2016; 11(9):e0163561. PubMed ID: 27662211
[TBL] [Abstract][Full Text] [Related]
19. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
